# GANZYK-RTU
> **NDA209347** · New Drug Application · Sponsor: EXELA PHARMA · Approved 2017-02-17
## Drug
- **FDA Application Number:** NDA209347
- **Application type:** New Drug Application
- **Brand name:** GANZYK-RTU
- **Generic name:** Ganciclovir
- **Active ingredients:** GANCICLOVIR
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** EXELA PHARMA
- **First approval:** 2017-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209347)
---
*AI Analytics · CC0 1.0*